$JFTH
Stock $jfth

$jfth Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000159991624000203 Filed on August 13, 2024

Income Statement

Concept	2024	2023
Revenue	$15.90K	$1.000K
YoY Change	1490.2%
Cost Of Revenue
YoY Change
Gross Profit	$15.92K	$1.038K
YoY Change	1433.91%
Gross Profit Margin	100.13%	103.8%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$0.00	$66.42K
YoY Change	-100.0%
% of Gross Profit	0.0%	6399.04%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$274.6K	$326.4K
YoY Change	-15.88%	-68.83%
Operating Profit	-$258.7K	-$325.4K
YoY Change	-20.51%	-68.93%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax	-$530.00	-$774.00
% Of Pretax Income
Net Earnings	-$761.8K	-$321.8K
YoY Change	136.73%	-69.27%
Net Earnings / Revenue	-4790.83%	-32182.0%
Basic Earnings Per Share	-$0.06	-$0.03
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding		12.85M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2024	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$8.741K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$21.61K
YoY Change	-96.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$21.61K
Total Long-Term Assets	$0.00
Total Assets	$21.61K
YoY Change	-96.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.017K
YoY Change	-86.25%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$50.02K
YoY Change	24.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.137M
YoY Change	55.42%
Common Stock	$1.371K
YoY Change	4.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$28.41K
YoY Change
Total Liabilities & Shareholders Equity	$21.61K
YoY Change	-96.01%

Cashflow Statement

Concept	2024	2023
OPERATING ACTIVITIES
Net Income	-$761.8K	-$321.8K
YoY Change	136.73%	-69.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$256.9K	-$293.6K
YoY Change	-12.49%	569.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$3.804K	-$527.7K
YoY Change	-99.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$276.9K	$854.6K
YoY Change	-67.59%	1848.38%
NET CHANGE
Cash From Operating Activities	-$256.9K	-$293.6K
Cash From Investing Activities	-$3.804K	-$527.7K
Cash From Financing Activities	$276.9K	$854.6K
Net Change In Cash	$7.376K	$1.365K
YoY Change	440.37%
FREE CASH FLOW
Cash From Operating Activities	-$256.9K	-$293.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001857910
CY2024Q1	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties		usd
CY2024Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent		usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent		usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023	DRFS	Creditlossesrelatedparty Creditlossesrelatedparty		usd
CY2023	DRFS	Otherincomeduration Otherincomeduration		usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding		shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding		shares
CY2023	DRFS	Creditlossesrelatedpartyperiod Creditlossesrelatedpartyperiod		usd
CY2023	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease		usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2024	us-gaap	Interest Paid InterestPaid		usd
CY2023	us-gaap	Interest Paid InterestPaid		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Entity File Number EntityFileNumber	000-5627
CY2024	dei	Entity Registrant Name EntityRegistrantName	Japan food tech holdings, inc.
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	3290088	usd
CY2024Q3	us-gaap	Shares Outstanding SharesOutstanding	95708699	shares
CY2024	dei	Auditor Firm AuditorFirmId	2738
CY2024	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2024	dei	Auditor Firm AuditorFirmId	2738
CY2024	dei	Auditor Location AuditorLocation	The Woodlands, TX
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8741	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1365	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	11333	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	384	usd
CY2024Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1532	usd
CY2023Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	567	usd
CY2023Q1	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	535460	usd
CY2023Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	4402	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	21606	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	542178	usd
CY2024Q1	us-gaap	Assets Assets	21606	usd
CY2023Q1	us-gaap	Assets Assets	542178	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1017	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	7396	usd
CY2024Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	48142	usd
CY2023Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	29524	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	328	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2705	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	532	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	497	usd
CY2024Q1	us-gaap	Liabilities Liabilities	50019	usd
CY2023Q1	us-gaap	Liabilities Liabilities	40122	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4800000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13708699	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13114888	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13114888	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1371	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1312	usd
CY2024Q1	DRFS	Foreigncurrencytranslationadjustment Foreigncurrencytranslationadjustment	-69245	usd
CY2023Q1	DRFS	Foreigncurrencytranslationadjustment Foreigncurrencytranslationadjustment	-23683	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2175985	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1899114	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2136525	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1374688	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-28413	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	502056	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21606	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	542178	usd
CY2024	us-gaap	Revenues Revenues	15902	usd
CY2023	us-gaap	Revenues Revenues	1000	usd
CY2024	DRFS	Revenuesrelatedparty Revenuesrelatedparty	20	usd
CY2023	DRFS	Revenuesrelatedparty Revenuesrelatedparty	38	usd
CY2024	DRFS	Totalrevenues Totalrevenues	15922	usd
CY2023	DRFS	Totalrevenues Totalrevenues	1038	usd
CY2024	us-gaap	Gross Profit GrossProfit	15922	usd
CY2023	us-gaap	Gross Profit GrossProfit	1038	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	274581	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	326423	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	274581	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	326423	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-258659	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-325385	usd
CY2024	DRFS	Creditlossesrelatedparty Creditlossesrelatedparty	-507709	usd
CY2024	us-gaap	Interest And Other Income InterestAndOtherIncome	5338	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	4339	usd
CY2024	DRFS	Otherincomeduration Otherincomeduration	-277	usd
CY2024	DRFS	Interest And Other Incometotal InterestAndOtherIncometotal	-502648	usd
CY2023	DRFS	Interest And Other Incometotal InterestAndOtherIncometotal	4339	usd
CY2024	DRFS	Netincomelossbeforetax Netincomelossbeforetax	-761307	usd
CY2023	DRFS	Netincomelossbeforetax Netincomelossbeforetax	-321046	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-530	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-774	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-761837	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-321820	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-45562	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-23683	usd
CY2024	DRFS	Total Comprehensive Income Loss Tax TotalComprehensiveIncomeLossTax	-807399	usd
CY2023	DRFS	Total Comprehensive Income Loss Tax TotalComprehensiveIncomeLossTax	-345503	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	13601618	shares
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	12853560	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11576427	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7000	usd
CY2023	DRFS	Commonsharessoldperiod Commonsharessoldperiod	769231	usd
CY2023	DRFS	Proceeds From Contributionssubsidiary ProceedsFromContributionssubsidiary	17754	usd
CY2023	DRFS	Proceeds From Contributions ProceedsFromContributions	67574	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-321820	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-23683	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13114888	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	502056	usd
CY2024	DRFS	Commonsharessoldperiod Commonsharessoldperiod	187050	usd
CY2024	DRFS	Proceeds From Contributions ProceedsFromContributions	89880	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-761837	usd
CY2024	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-45562	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13708699	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28413	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-761837	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-321820	usd
CY2024	DRFS	Creditlossesrelatedpartyperiod Creditlossesrelatedpartyperiod	507709	usd
CY2024	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-11513	usd
CY2023	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-379	usd
CY2024	DRFS	Advancepayments Advancepayments	-1081	usd
CY2023	DRFS	Advancepayments Advancepayments	-558	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5765	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	29692	usd
CY2024	DRFS	Increase Decrease In Accounts Payablerelatedparty IncreaseDecreaseInAccountsPayablerelatedparty	23148	usd
CY2023	DRFS	Increase Decrease In Accounts Payablerelatedparty IncreaseDecreaseInAccountsPayablerelatedparty	7504	usd
CY2024	DRFS	Interestreceivableperiodrleatedparty Interestreceivableperiodrleatedparty	-5338	usd
CY2023	DRFS	Interestreceivableperiodrleatedparty Interestreceivableperiodrleatedparty	-4338	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2705	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4234	usd
CY2024	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	343	usd
CY2024	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	99	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	505	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-256940	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-293628	usd
CY2024	DRFS	Loantorelatedpartyincreasedecrease Loantorelatedpartyincreasedecrease	-121032	usd
CY2023	DRFS	Loantorelatedpartyincreasedecrease Loantorelatedpartyincreasedecrease	-710700	usd
CY2024	DRFS	Paymentsreceivedfromrelatedpartyloan Paymentsreceivedfromrelatedpartyloan	117228	usd
CY2023	DRFS	Paymentsreceivedfromrelatedpartyloan Paymentsreceivedfromrelatedpartyloan	183025	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3804	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-527675	usd
CY2024	DRFS	Cashreceivedforcommonstock Cashreceivedforcommonstock	187050	usd
CY2023	DRFS	Cashreceivedforcommonstock Cashreceivedforcommonstock	769231	usd
CY2024	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	89880	usd
CY2023	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	85328	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	276930	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	854559	usd
CY2024	DRFS	Neteffectofexchangeratechangesoncash Neteffectofexchangeratechangesoncash	-8810	usd
CY2023	DRFS	Neteffectofexchangeratechangesoncash Neteffectofexchangeratechangesoncash	-31891	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7376	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1365	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1365	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8741	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1365	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	532	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zgLNKxQrR1wg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_862_zBz61X0hrAaf">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary to make the financial statements not misleading have been included. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024	us-gaap	Advertising Expense AdvertisingExpense	16400	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2024Q1	DRFS	Cashandcashequivalentsasof Cashandcashequivalentsasof	8741	usd
CY2023Q1	DRFS	Cashandcashequivalentsasof Cashandcashequivalentsasof	1365	usd
CY2024	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<p id="xdx_84F_eus-gaap--FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_zre7aRcbISKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86D_zv9g0BZFoOS4">Accounts Receivable and Credit Policies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Accounts receivable are recognized and carried at the original invoice amount less allowance for any uncollectible amounts. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Bad debts are written off as incurred. Accounts receivable totaled $<span id="xdx_902_ecustom--Accountsreceivableasof_iI_c20240331_zGrL9CNnHrX" title="accounts receivable">11,333</span> and $<span id="xdx_90A_ecustom--Accountsreceivableasof_iI_c20230331_zyaYyNEFx2tj" title="accounts receivable">384</span> as of March 31, 2024 and March 31, 2023, respectively. Allowances for doubtful accounts were $0 for both years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q1	DRFS	Accountsreceivableasof Accountsreceivableasof	11333	usd
CY2023Q1	DRFS	Accountsreceivableasof Accountsreceivableasof	384	usd
CY2024	DRFS	Accountsreceivableowedbycustomers Accountsreceivableowedbycustomers	9467	usd
CY2023	DRFS	Accountsreceivableowedbycustomers Accountsreceivableowedbycustomers	384	usd
CY2024	us-gaap	Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure	<p id="xdx_840_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_zYJlBbvLXHsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_868_zRwaYYOsKol">Revenue Recognition</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASC 606, <i>Revenue from Contracts with Customers</i> (Topic 606) (“ASC 606”), in the third quarter of fiscal year 2023, as this was the first quarter that the Company generated revenues. Under ASC 606, the Company recognizes revenue when a customer obtains control of promised goods, in an amount that reflects the consideration that the Company expects to receive in exchange for the goods. To determine revenue recognition for arrangements within the scope of ASC 606, the Company performs the following five steps: (1) identify the contracts with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when or as the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods it transfers to the customer. Under ASC 606, disaggregated revenue from contracts with customers depicts the nature, amount, timing, and uncertainty of revenue and cash flows affected by economic factors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">Revenue from product sales</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize revenue upon transfer of control of our promised goods in an amount that reflects the consideration we expect to be entitled to in exchange for those goods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For our primary transaction-based revenue source we have determined we are acting as an agent in the transactions and, therefore, a net presentation (that is, the amount billed to a customer less the amount paid to a supplier). Net presentation is appropriate for the majority of our revenue transactions as the supplier is primarily responsible for providing the underlying goods and services and we do not control the goods provided by the supplier to the customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue for products is recognized when the products are delivered to the customer and the customer completes the product inspection. Cash receipts for undelivered products are recorded as deferred revenues. As of March 31, 2024 and March 31, 2023, the Company had deferred revenues related to product sales of $328 and $0, respectively. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s revenue consists of food product sales through its subsidiary, Dr. Foods Co., Ltd. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">Revenue - related party</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify">During the years ended March 31, 2024 and March 31, 2023, revenue totaling approximately $20 and $38, respectively, was recognized from sales to related party WB Burgers Japan Co. Ltd. (hereinafter referred to as “WBBJ”). WBBJ is considered to be a related party due to the fact that Koichi Ishizuka, CEO of the Company, indirectly controls WBBJ through his share ownership of WB Burgers Asia, Inc. The terms and conditions applied to the above transactions were the same as those applied to sales to customers not related to the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify">The Company’s revenue consists of food product sales through its subsidiary, Dr. Foods Co., Ltd. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p>
CY2024	DRFS	Revenuefromcustomers Revenuefromcustomers	13693	usd
CY2023	DRFS	Revenuefromcustomers Revenuefromcustomers	976	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	66422	usd
CY2024Q1	DRFS	Netlossasof Netlossasof	2136525	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	448670	usd
CY2024	DRFS	Companydeferredtaxassets Companydeferredtaxassets	<p id="xdx_898_ecustom--Companydeferredtaxassets_zKdT6c9f1CI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_8B4_zVADH1Z7SDw1">Significant components of the Company’s deferred tax assets</span> are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Aptos; width: 100%"> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td colspan="5" style="border-bottom: black 1pt solid; vertical-align: top; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td colspan="5" style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: top; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax asset, generated from net operating loss</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">448,670</span><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,684</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (448,670)</span><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 11.65pt"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(288,684)</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> </table> <p style="font: 10pt/10.5pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/10.5pt Times New Roman, Times, Serif; margin: 0">The reconciliation of the effective income tax rate to the federal statutory rate is as follows:</p> <p style="font: 10pt/10.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Aptos; width: 100%; background-color: white"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 92%; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal income tax rate 21.0%</span></td> <td style="width: 1%; line-height: 11.65pt"> </td> <td style="width: 1%; line-height: 11.65pt"> </td> <td style="width: 5%; text-align: right; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.0</span></td> <td style="width: 1%; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase in valuation allowance (21.0%)</span></td> <td style="line-height: 11.65pt"> </td> <td style="line-height: 11.65pt"> </td> <td style="text-align: right; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21.0</span></td> <td style="line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%)</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective income tax rate 0.0%</span></td> <td style="line-height: 11.65pt"> </td> <td style="line-height: 11.65pt"> </td> <td style="text-align: right; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0</span></td> <td style="line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table>
CY2024	DRFS	Expensespaidbyofficerduringyear Expensespaidbyofficerduringyear	89880	usd
CY2023	DRFS	Expensespaidbyofficerduringyear Expensespaidbyofficerduringyear	67574	usd
CY2023	DRFS	Officercontributedcapital Officercontributedcapital	17754	usd
CY2023	DRFS	Loanedtowhiteknightco Loanedtowhiteknightco	710700	usd
CY2023	DRFS	Repaymentfromwhiteknight Repaymentfromwhiteknight	183025	usd
CY2023	DRFS	Whiteknightloaninterest Whiteknightloaninterest	4338	usd
CY2023	DRFS	Whiteknighttotalaccruedloaninterestduring Whiteknighttotalaccruedloaninterestduring	4402	usd
CY2024	DRFS	Loanedtowhiteknightco Loanedtowhiteknightco	121032	usd
CY2024	DRFS	Repaymentfromwhiteknight Repaymentfromwhiteknight	117228	usd
CY2024	DRFS	Whiteknightloaninterest Whiteknightloaninterest	5338	usd
CY2024Q1	DRFS	Totalloaninterestasof Totalloaninterestasof	8980	usd
CY2024	DRFS	Invoicesfrommamafoods Invoicesfrommamafoods	8984	usd
CY2023	DRFS	Invoicesfrommamafoods Invoicesfrommamafoods	0	usd
CY2024	DRFS	Invoicesfromnextmeatsco Invoicesfromnextmeatsco	14031	usd
CY2023	DRFS	Invoicesfromnextmeatsco Invoicesfromnextmeatsco	11517	usd
CY2023	DRFS	Invoicesfromofficer Invoicesfromofficer	18007	usd
CY2024	DRFS	Invoicesfromofficer Invoicesfromofficer	7120	usd
CY2024Q1	DRFS	Totalowedtoofficerbycompany Totalowedtoofficerbycompany	25127	usd
CY2024	DRFS	Expensespaidbysoleofficer Expensespaidbysoleofficer	89880	usd
CY2023	DRFS	Expensespaidbysoleofficer Expensespaidbysoleofficer	67574	usd
CY2024	DRFS	Unfulfilledorders Unfulfilledorders	328	usd

Files In Submission

Name	View Source	Status
0001599916-24-000203-index-headers.html	Edgar Link	pending
0001599916-24-000203-index.html	Edgar Link	pending
0001599916-24-000203.txt	Edgar Link	pending
0001599916-24-000203-xbrl.zip	Edgar Link	pending
drfs-20240331.xsd	Edgar Link	pending
drfs_10k24o.htm	Edgar Link	pending
exhibit31.htm	Edgar Link	pending
exhibit32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
image_024.jpg	Edgar Link	pending
image_025.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
drfs-20240331_cal.xml	Edgar Link	unprocessable
drfs-20240331_def.xml	Edgar Link	unprocessable
drfs-20240331_lab.xml	Edgar Link	unprocessable
drfs-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
drfs_10k24o_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JFTH
Stock $jfth

2024 Q1 Form 10-K Financial Statement

#000159991624000203 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JFTH Stock $jfth

2024 Q1 Form 10-K Financial Statement

#000159991624000203 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JFTH
Stock $jfth